BioSpace News Archive

The Corporate Whistleblower Center says, “We have one of the most aggressive initiatives in the nation focused of federal taxpayers being ripped off with waste, abuse and fraud.

Surmodics, Inc. announced that Gary Maharaj, president and chief executive officer, and Tim Arens, vice president of finance and chief financial officer, will make a presentation to the investment community at the Jefferies 2019 Healthcare Conference in New York City on Tuesday, June 4, 2019, at 10:30 a.m. ET (9:30 a.m. CT).

National Mental Health Month in May promotes awareness about mental illness and how it affects everyday people.

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular drug manufacturer in China’s prescription drug market, announced the third generation of EGFR inhibitor XZP-5809, a Category 1 innovative drug developed by the Group, has been granted drug clinical trial approval by the National Medical Products Administration of the PRC.

Zymeworks Inc. announced that it has earned a milestone payment from Merck achieved under the companies’ 2014 research and license agreement.

Team also strengthened with key hires in preclinical and clinical development, clinical operations, and finance to drive company’s lead program into the clinic in 2020 and advance its pipeline and MAP platform

Mallinckrodt plc, a global specialty biopharmaceutical company, is reporting data1 from the open-label part of the Phase 4, multicenter study assessing the efficacy and safety of Acthar® Gel in patients with persistently active rheumatoid arthritis who were previously treated with disease-modifying anti-rheumatic drugs and corticosteroids.

Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is pleased to announce the 510 clearance of QUANTA Flash® Rheumatoid Factor IgM and QUANTA Flash RF IgA assays by the US Food and Drug Administration.

Anixa Biosciences, Inc. announced that it will present updated data from its study utilizing Cchek™, its artificial intelligence driven early cancer detection technology, at CYTO 2019 – 34th Congress of the International Society for Advancement of Cytometry in Vancouver, BC, Canada.

Each year, about one billion people worldwide are affected by influenza epidemics, over five million of these with serious outcomes.